Altimmune (ALT) director makes open-market share purchase

Altimmune, Inc. director John Gill purchased 9,200 shares of common stock on the open market at a weighted average price of $3.4076 per share, totaling approximately $31,350. This transaction increases his direct holdings to 21,700 shares. The purchase, made in multiple trades between $3.4050 and $3.4080, signals a positive sentiment from an insider.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin